- All sections
- B - Performing operationstransporting
- B01D - Separation
- B01D 15/24 - Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
Patent holdings for IPC class B01D 15/24
Total number of patents in this class: 149
10-year publication summary
|
6
|
19
|
13
|
11
|
10
|
12
|
20
|
9
|
10
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shimadzu Corporation | 6370 |
17 |
| Agilent Technologies, Inc. | 2640 |
10 |
| Waters Technologies Corporation | 1799 |
7 |
| Cytiva Sweden AB | 791 |
7 |
| Amgen Inc. | 4436 |
5 |
| Sartorius Stedim Biotech GmbH | 881 |
5 |
| EMD Millipore Corporation | 633 |
4 |
| United Therapeutics Corporation | 331 |
4 |
| Board of Regents, The University of Texas System | 6149 |
3 |
| Bio-Rad Laboratories, Inc. | 1612 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
3 |
| Cytiva BioProcess R&D AB | 325 |
3 |
| Sanofi-Aventis Deutschland GmbH | 2588 |
2 |
| Battelle Energy Alliance, LLC | 589 |
2 |
| Biotage AB | 96 |
2 |
| Cambridge Enterprise Limited | 1246 |
2 |
| ChromaCon AG | 41 |
2 |
| GE Healthcare Bio-Sciences AB | 508 |
2 |
| IFP Energies Nouvelles | 3110 |
2 |
| Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1852 |
2 |
| Other owners | 62 |